Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease

BACKGROUND: Prospectively and systematically collected long-term real-world clinical data on ustekinumab (anti-interleukin-12/23) are still scarce. AIMS: To assess the long-term effectiveness of ustekinumab in patients with active Crohn’s disease (CD). METHODS: This is a prospective multicenter stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Forss, Anders, Clements, Mark, Myrelid, Pär, Strid, Hans, Söderman, Charlotte, Wagner, Agnieszka, Andersson, David, Hjelm, Fredrik, Olén, Ola, Halfvarson, Jonas, Ludvigsson, Jonas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883312/
https://www.ncbi.nlm.nih.gov/pubmed/35459973
http://dx.doi.org/10.1007/s10620-022-07501-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883312/
https://www.ncbi.nlm.nih.gov/pubmed/35459973
http://dx.doi.org/10.1007/s10620-022-07501-z

Ejemplares similares